Representative Matters
Repräsentative Angelegenheiten
代表事项
Public Company Transactions
- Chiasma, a late-stage biopharmaceutical company, in its $102 million initial public offering on the NASDAQ Stock Market
- J.P. Morgan and Barclays Capital in the $184 million initial public offering of Intrexon Corporation, a synthetic biology company, on the NYSE
- J.P. Morgan and BofA Merrill Lynch in the $116 million follow-on offering of Intrexon Corporation
- JMP Securities in the $230 million follow-on offering of Intrexon Corporation
- Cantor Fitzgerald in a $200 million “at the market” offering facility for Intrexon Corporation
- Foundation Medicine, a cancer diagnostics company, in (i) its $120 million initial public offering on the NASDAQ Stock Market and (ii) its collaboration agreement and equity transaction with Roche, total value in excess of $1 billion
- Ocera Therapeutics, a biotechnology company, in its $28 million PIPE financing, $25 million public offering and $25 million “at the market” offering facility
- Vivo Capital in its participation in a $12.5 million unit offering of BioPharmX
- Vivo Capital, as lead investor, in a $35 million financing of Strongbridge Pharma
M&A
- Represented Thar Pharmaceuticals, a biopharmaceutical company, in its acquisition by an affiliate of The Grünenthal Group
- Songza, a streaming music company, in its sale to Google
- M5 Networks, a cloud communications company, in its $146 million acquisition by ShorTel
- XGraph, a social targeting company, in its acquisition by Add This (formerly Clearspring)
- Fidelis Security Systems, a cybersecurity company, in its acquisition by General Dynamics
- Nomi Technologies, a retail technology company, in its acquisition by Brickstream Corporation
- Represented Tagman, the pioneer tag management and attribution company, in its acquisition by Ensighten
Venture Financings
- Celtra in its $15.0 million financing by affiliates of WPP and Unilever
- Syntimmune in its $50.0 million financing led by Apple Tree Partners
- Glasswing Ventures as lead investor in an $8.3 million financing of Talla
- PatientBank in its $2.2 million financing led by General Catalyst and Khosla Ventures with participation by SV Angels, Spectrum 28 and Data Collective
- Hubble Contacts in its $16.5 million financing led by First Mark Capital, Greycroft, Two River and Wildcat Capital Management
- Glossier in its $24 million Series B financing led by Institutional Venture Partners, with participation from Index Ventures, Thrive Capital and Forerunner Ventures
- Hubble Contacts in $7.2 million seed financings backed by Wildcat Capital Management, Two River, Founders Fund and Greycroft Partners
- Aircall.io in its $8 million financing led by Baldteron Capital
- Allena Pharmaceuticals in its $53 million Series C financing led by Partner Fund Management, Fidelity and Wellington
- Codiak BioSciences in its $80 million financing led by Arch Venture Partners and Flagship Ventures
- InterWest and Orbimed, as lead investors, in a $32 million investment round of Avedro
- HYPR Brands in its $5 million financing led by Silvertech Ventures, Edgewater Equity and a number of other strategic investors.
- Precision Biologics in its $50 million financing by an affiliate of NantWorks
- Orchard Platform in its $30 million financing led by Thrive Capital, Spark Capital and Canaan Partners
- Even Financial in its $2.8 million financing led by Canaan Partners and Lerer Hippeau Ventures
- Into the Gloss (d/b/a Glossier) in its $8.4 million financing led by Thrive Capital
- Pond5 in its $61 million financing by Accel Partners and Stripes Group
- Paperless Post in its $25 million financing led by August Capital
- Megaphone TV in its $4.3 million financing led by Softbank Korea
- Nomi Technologies in its $10 million financing by Accel Partners, First Round Capital, Greycroft Partners and Forerunner
Professional Activities
Mr. Lang is a frequent lecturer at the Cardozo Tech Law Start Up Clinic, Columbia Business School, Columbia Law School, Cornell Tech and eLab NYC on venture financings and other elements of start-up law.
Professional Experience
Prior to joining Goodwin, Mr. Lang was an associate in the New York office of Heller Ehrman.